$164.23 +4.46 (%) Salix Pharmaceuticals Ltd - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD | Sep. 19, 2014 | 18:35PM EST
  2. Salix Secures Additional Intellectual Property Relating To Rifaximin

    Benzinga | Sep. 18, 2014 | 07:31AM EST
  3. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD | Sep. 16, 2014 | 12:12PM EST
  4. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  5. UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

    Benzinga | Sep. 15, 2014 | 17:32PM EST
  6. Nasdaq Sinks As Tesla, Other Highfliers Get Hit

    IBD | Sep. 15, 2014 | 16:31PM EST
  7. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  8. Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, Ltd.

    Benzinga | Sep. 12, 2014 | 11:28AM EST
  9. Stocks Drag Lower Despite Data; Conversant Soars On ADS Buyout

    IBD | Sep. 12, 2014 | 10:37AM EST
  10. IBD 50 Showing Little Distress, But Few Big Winners

    IBD | Sep. 5, 2014 | 18:45PM EST
  11. Four Stock Spotlight Names Near Buy Points

    IBD | Sep. 5, 2014 | 18:45PM EST
  12. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  13. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  14. After Big Run, Does Chip Designer NXP Have More Left?

    IBD | Aug. 26, 2014 | 17:27PM EST
  15. S&P 500 Marks New High As Indexes Hold Gains

    IBD | Aug. 21, 2014 | 16:30PM EST
  16. SALIX PHARMACEUTICALS

    IBD | Aug. 20, 2014 | 18:56PM EST
  17. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD | Aug. 20, 2014 | 13:11PM EST
  18. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga | Aug. 19, 2014 | 19:31PM EST
  19. Salix Soars On Allergan Buzz

    IBD | Aug. 19, 2014 | 18:50PM EST
  20. Indexes Rally On Strong Housing Data, Retail Reports

    IBD | Aug. 19, 2014 | 17:03PM EST
  21. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD | Aug. 19, 2014 | 15:13PM EST
  22. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD | Aug. 19, 2014 | 14:28PM EST
  23. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

    Benzinga | Aug. 19, 2014 | 14:02PM EST
  24. Near Entries: Cavium, Autohome, Skyworks And Facebook

    IBD | Aug. 18, 2014 | 18:34PM EST
  25. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Aug. 11, 2014 | 07:44AM EST
  26. Leaders Actavis, Salix Trip Sell Signals

    IBD | Aug. 8, 2014 | 18:37PM EST
  27. Easing Tensions Push Stocks Up In Afternoon Trade

    IBD | Aug. 8, 2014 | 16:25PM EST
  28. Stocks Sharply Higher As Russia Ends Maneuvers

    IBD | Aug. 8, 2014 | 14:46PM EST
  29. Stocks Up Despite Airstrikes; Nvidia, Monster, Ubiquiti Soar

    IBD | Aug. 8, 2014 | 10:30AM EST
  30. Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results

    Benzinga | Aug. 8, 2014 | 09:19AM EST
  31. Sterne Agee Adjusts Estimates For Salix Pharmaceuticals

    Benzinga | Aug. 8, 2014 | 09:17AM EST
  32. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD | Aug. 7, 2014 | 18:50PM EST
  33. Salix misses, guidance in line

    IBD | Aug. 7, 2014 | 18:41PM EST
  34. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  35. Earnings Scheduled For August 7, 2014

    Benzinga | Aug. 7, 2014 | 05:35AM EST
  36. Top Performing Funds Play Favorits

    IBD | Aug. 5, 2014 | 18:30PM EST
  37. Prescription Drugmakers Slide Down Industry Rankings

    IBD | Aug. 4, 2014 | 18:35PM EST
  38. 5 Drug Companies Profiting From Generics

    Benzinga | Aug. 4, 2014 | 08:29AM EST
  39. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD | Aug. 2, 2014 | 08:02AM EST
  40. TAL Education, Team Health Join The IBD 50 Resistance

    IBD | Aug. 1, 2014 | 19:08PM EST
  41. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus | Jul. 31, 2014 | 11:18AM EST
  42. Tough Sledding For Growth Stocks Amid Market Distribution

    IBD | Jul. 17, 2014 | 18:28PM EST
  43. US Stock Futures Tumble Ahead Of Morgan Stanley Earnings

    Benzinga | Jul. 17, 2014 | 07:29AM EST
  44. Morning Market Movers

    Benzinga | Jul. 14, 2014 | 09:38AM EST
  45. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 14, 2014 | 08:10AM EST
  46. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga | Jul. 14, 2014 | 07:29AM EST
  47. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation III Approves Salix Request For FDA Approval Of RELISTOR sNDA

    Benzinga | Jul. 14, 2014 | 07:06AM EST
  48. Progenics Announces Will Host Call Related to FDA Appeal Response Related to RELISTOR sNDA

    Benzinga | Jul. 14, 2014 | 07:06AM EST
  49. Salix deal underwhelms Street

    IBD | Jul. 9, 2014 | 18:45PM EST
  50. Salix Pharmaceutical's Inversion Deal Makes It Unlikely Merger Target, Dilutes EPS

    Benzinga | Jul. 9, 2014 | 16:12PM EST
Trading Center